SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-078988
Filing Date
2016-09-06
Accepted
2016-09-06 18:20:28
Documents
2
Period of Report
2016-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1673
2 SECTION 16 POWER OF ATTORNEY poa_nisen.htm EX-24.4 7923
  Complete submission text file 0001140361-16-078988.txt   10915
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Issuer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 WOODWARD STREET, SUITE 100 AUSTIN TX 78744
Business Address
Nisen Perry (Reporting) CIK: 0001683791 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37566 | Film No.: 161871760